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AbstrAct
Introduction Patients with lung cancer may present with 
additional lesions in the central airways. Earlier studies 
have shown a relationship between vessel diameter, 
pattern and grade of malignancy. High-definition (HD+) 
bronchoscopy with image enhancement techniques 
(i-scan) detected more vascular abnormalities but 
correlation with pathology has not yet been established.
Methods In this investigator-initiated, randomised, 
controlled, crossover, multicentre study in patients 
with suspected lung cancer, a HD+ bronchoscopy was 
performed with i-scan1 and i-scan2 settings in random 
order. Biopsies, visual grade and vascular pattern 
classification were obtained by endoscopists and blinded 
evaluation.
results In 107 patients, vascular patterns were classified 
in 48 tumours. Abrupt-ending vessels were predominantly 
found in squamous cell carcinoma but overall correlation 
between vessel pattern and histology was not significant 
(p=0.339). Additional lesions were detected in 35 patients 
(33%) with a correlation between vessel pattern and 
high-grade (pre-)invasive lesions (p<0.001). In 8.4% of 
the patients, relevant second lesions were detected which 
determined treatment and staging in 3% of all patients. 
Interobserver agreement was excellent for visual grading 
of the airway epithelium, but low for classifying vascular 
patterns. No significant detection rate difference was found 
by blinded and unblinded evaluation.
conclusion HD+ bronchoscopy with i-scan image 
enhancement readily detects additional lesions. In one-
third of all the patients, additional lesions were detected. 
Their vascular pattern correlates to pathology outcome, 
but the interobserver correlation for vascular pattern 
classification is low. These lesions were relevant in 8.4% 
and affected treatment and work-up in 3% of the cases.
trial registration number NCT02285426; Results.
IntroductIon
Bronchoscopy is one of the most important 
diagnostic procedures in lung cancer. This 
procedure not only aims to obtain a diag-
nosis but also renders important anatomical 
information. Furthermore, subtle changes in 
the airway epithelium and vascular patterns 
of the bronchial tree are clues to guide the 
endoscopist to the site of biopsy, help to 
determine resectability or local treatment in 
case of centrally located lung cancer and is 
the only tool to detect multifocal premalig-
nant disease.
Three meta-analyses showed diagnostic 
superiority of autofluorescence bronchos-
copy (AFB) over routine white light bron-
choscopy (WLB) in detecting premalignant 
lesions.1–3 The superiority of AFB over WLB 
is especially significant in older studies using 
fiberoptic endoscopes. The use of video-en-
doscopes further improved detection in the 
AFB setting.4–6 Yet AFB is not widely used and 
is available in a few specialised centres only. 
In the most recent guideline of the American 
College of Chest Physicians, the use of AFB is 
recommended ‘when available’.7 Uncertainty 
on the natural history and the risk of progres-
sion from premalignant lesions to invasive 
carcinoma and the high rate of false positive 
Key messages
 ► Can bronchoscopes equipped with real-time per 
pixel image enhancement technology detect more 
lesions with subtle changes in epithelial vascular 
patterns in patients with lung cancer, is there a 
relation between vessel pattern and pathology of 
tumours and/or premalignant lesions and are these 
lesions clinically relevant?
 ► This study shows that high-definition bronchoscopy 
with real-time image enhancement detects 
additional separate lesions in one-third of all 
patients and shows that the classification of 
vascular pattern correlates with the grade of 
premalignant second lesions.
 ► This study also shows that the interobserver 
agreement for classification of these vascular 
lesions is low and that clinically relevant second 
lesions were detected in 8% of the cases and 
influenced treatment in 3%, underlining the role 
for routine endobronchial evaluation in all new 
patients with lung cancer and the need for training 
to classify vessel patterns better.
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AFB findings further question its use.7 However, AFB 
surveillance in a high-risk group appeared to significantly 
contribute in detecting new tumours in high-risk patients 
with known preinvasive lesions where 62% of the lung 
cancers were detected by AFB compared with 38% by 
CT.8 In a time where endo-bronchial ultrasound (EBUS) 
often is being used as the first and sole diagnostic proce-
dure in patients with suspected lung cancer, this finding 
may support the need for systematic bronchoscopic eval-
uation in all cases.
Alternatively, the use of filters transmitting only part 
of the white light (narrow band imaging (NBI)) has 
been shown to be of additional value to detect angio-
genic squamous dysplasia (as a precursor for invasive 
tumours)9–11 and was reported to be approximately equal 
to (video-)AFB in terms of sensitivity and had slightly 
better specificity.12 13 The type of vascular pattern was also 
related to histological subtype; dotted vessels correlated 
to adenocarcinoma (AC) and abrupt vessel endings to 
squamous-cell carcinoma (SqCC).13
Through technological improvement, new imaging 
techniques have become available in the form of 
high-definition (HD+) bronchoscopy. In combination 
with an improved video processor, this HD+ broncho-
scope offers postprocessing real-time image enhance-
ment (i-scan technology).14 In different settings, per pixel 
real-time adjustments can be made improving visualisa-
tion of minute changes in the epithelial layer (surface 
enhancement (SE)) and modify the colour spectrum 
(tone enhancement (TE)). In an earlier exploratory 
study, we found that HD+ bronchoscopy with i-scan image 
enhancement detected significantly more sites with 
abnormal and suspicious vascular patterns compared 
with routine WLB, AFB and HD+ bronchoscopy.15 In the 
evaluation of the gastrointestinal tract, real-time image 
enhancement has been shown to improve diagnostic 
yield.16 What the impact is of this i-scan technique with 
HD+ videobronchoscopy on the diagnostic performance 
is unknown. We hypothesise that image enhancement 
technology increases detection rate of synchronous 
lesions.
In this prospective investigator-initiated multicentre 
study, we therefore aim to investigate the diagnostic 
performance in daily clinical use of HD+ bronchoscopy, 
with or without SE or TE and relate visual imaging to 
biopsy outcome of all detected sites with abnormal and/
or suspicious vascular patterns in patients with suspected 
lung cancer. Furthermore, this study aims to determine if 
these findings as a result of systematic evaluation of the 
central airways influence clinical work-up or choice of 
treatment.
Methods
design
This study is an investigator-initiated, randomised, biop-
sy-controlled, crossover, multicentre study. Each patient 
served as its own control for pathology outcome and for 
blinded versus unblinded interobserver agreement anal-
ysis.
Patients and procedure
Patients with suspected lung cancer and an indica-
tion for diagnostic bronchoscopy following the local 
guidelines were included in four participating medical 
centres: Hospital Umberto I, Ravenna, Italy; St-Peters-
burg Research Institute of TB and Thoracic Surgery, 
Saint-Petersburg, Russia; Hospital Universitario Santa 
Lucia, Murcia, Spain; and Radboudumc, Nijmegen, 
the Netherlands. Exclusion criteria were ASA physical 
status ≥4, age <18 years, bleeding disorders, indication 
for the continued use of anticoagulant therapy, known 
allergy for lidocaine, known pulmonary hypertension, 
recent and/or uncontrolled cardiac disease, comprised 
upper airways, prior radiotherapy involving central 
airways, pregnancy and inability to consent. Patients were 
included from October 2014 until December 2016. 
study procedure
Patients underwent bronchoscopy investigating the 
entire bronchial tree with the use of local anaesthesia 
and type of sedation in accordance with local protocol. 
All bronchoscopies were performed using the HD+ bron-
choscope EB-1990i (Pentax, Japan) in combination with 
the EPK-I series processors (EPK-i7000, EPK-i5000 or 
EPK-I, Pentax). Three different imaging modes were 
used as described earlier (see figure 1): HD+ (settings: 
brightness +0 average, redness 0, enhancement level +4, 
SE +0, TE off, colour enhancement off, noise reduc-
tion low); i-scan 1=HD+ SE (HD with SE settings: bright-
ness +0 average, redness 0, enhancement level +4, SE +4, 
TE off, colour enhancement off, noise reduction low); 
and i-scan-2=HD+SE+TE (HD with SE and TE; settings: 
brightness +1 average, redness 0, enhancement level +4, 
SE +4, TE colon, colour enhancement off, noise reduc-
tion low).15
The order of different modes was randomised to avoid 
scope-induced and/or cough lesion bias. Videos were 
made for each mode and stored without patient identifica-
tion information.
Tissue biopsies were taken from the tumour site and all 
sites with vascular abnormalities detected by the unblinded 
bronchoscopist after changing to a normal bronchoscope 
with a larger working channel. In addition, tissue biopsies 
from a normal secondary carina on the contralateral site 
were taken as a control sample when vascular lesions were 
detected and biopsied. New biopsy forceps were used for 
each anatomically different location to avoid cross-contam-
ination. The gold standard was histology of biopsies graded 
according to the WHO International Histological Classifi-
cation of Tumours.17
All videos were reviewed separately by four experienced 
investigators (EHFMvdH, WH, OCJS and AvdV) in random 
order and blinded for initial classifications and patient 
outcome. The central airway epithelial abnormalities were 
 o
n
 30 July 2018 by guest. Protected by copyright.
http://bmjopenrespres.bmj.com/
BM
J O
pen Resp Res: first published as 10.1136/bmjresp-2018-000295 on 18 May 2018. Downloaded from 
van der Heijden EHFM, et al. BMJ Open Resp Res 2018;5:e000295. doi:10.1136/bmjresp-2018-000295 3
Open Access
visually classified individually by both the bronchoscopist 
and the blinded readers of the video’s following the scoring 
system categorised as normal, abnormal, suspicious and 
tumour.5 12 In this scoring system, the following definitions 
were used: abnormal is defined as visible area of erythema, 
swelling and/or thickening of mucosa, airway inflamma-
tion, fibrosis, trauma or granulation tissue. Suspicious was 
scored when nodular, polypoid lesions, irregular mucosa 
and/or focal thickening of subcarina was present. Tumour 
is defined as a visible endobronchial tumour and normal 
as the absence of any of the above.5 12 Vascular abnormal-
ities are scored on vascular pattern following the Shibuya 
descriptors: tortuous, dotted and abrupt ending vessels 
(figure 1).11 13 This Shibuya classification was slightly modi-
fied; for this study, spiral and tortuous vessel patterns were 
grouped as one since differences between these two catego-
ries are difficult to define.
statistical analysis
With an estimated prevalence of additional lesions in 50% 
of the patients,12 13 15 the power analysis indicated that 130 
patients were needed for this diagnostic study.
Patient characteristics are given in means (SD) for 
continuous variables and in percentages or counts for cate-
gorical variables. Fisher’s exact tests (two-sided) cross-tab-
ulation tests were used to investigate the correlation 
between prospectively assessed tumour sites and the found 
vascular lesions, and their histological outcome. Cohen’s 
kappa concordance was calculated to assess the interob-
server agreement between prospectively (unblinded) and 
retrospectively (blinded) detected tumours and vascular 
lesions’ grading and classification. Wilcoxon signed-rank 
tests were used to evaluate differences between different 
image enhancement techniques in the blinded evaluation. 
Analyses were performed using STATA/SE V.11.2 software 
(Stata), and p<0.05 was considered statistically significant.
results
General findings
Of 294 potentially eligible patients, 134 patients were 
randomised and included in this study. From these, 8 
patients had an incomplete dataset, 14 were shown to have 
a benign disease and 5 were diagnosed with a malignant 
tumour other than lung cancer (singular cases of mela-
noma, liposarcoma, mesothelioma, lymphoma and papil-
lary adenoma). As a result, 107 patients with proven lung 
cancer were analysed (figure 2). Their baseline characteris-
tics are summarised in table 1.
Most lung cancers were located in the upper lobes, and 
based on imaging, suspected stage III lung cancer was most 
prevalent at the moment of bronchoscopy. The majority 
of bronchoscopies were performed under propofol seda-
tion or general anaesthesia (respectively 36% and 26%) or 
moderate sedation using 4.7±0.4 mg of midazolam (23%). 
In 14% of the cases, no sedation was used. In 27% of the 
procedures, fluoroscopy guidance was used. The average 
study procedure time was 11±0.8 min (table 1). Compli-
cations were reported in 10 cases: 5 patients needed local 
application of topical vasoconstrictive agents; no severe 
bleeding or pneumothoraxes were reported (table 1). The 
visual grading and pathology outcome are summarised in 
tables 2 and 3; SqCC and AC were most frequently diag-
nosed. Control biopsy specimens were obtained when 
vascular lesions were detected. The pathology results from 
Figure 1 Sample figures of typical bronchoscopy findings illustrating the effect of i-scan image enhancement technique 
and differences in vascular patterns. (A–C) A centrally located squamous cell carcinoma in the right main stem bronchus with 
high-definition bronchoscopy (A), surface enhancement (i-scan1, B) and the combination of surface and tone enhancement 
(i-scan 2, C). (D–F) Different vascular patterns are illustrated. (D) Tortuous or spiral vessels, (E) dotted vessels and (F) abrupt 
ending vessels.
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these control biopsy sites showed normal epithelium in 
62%, inflammation in 36% and squamous metaplasia in 
2% of the samples (table 3).
hd bronchoscopy visual grade and vascular pattern 
characterisation of target tumour area
In the 107 patients with lung cancer, the tumour target 
area was judged normal in 40 cases by the (unblinded) 
bronchoscopist, which indicates parenchymal localisation 
of the tumour beyond the visible part of the central airways 
and the subsegmental bronchi. In 56 cases, the target 
area was classified as tumour, and in 7 cases the epithe-
lial surface in the target area was classified as suspicious 
(table 2). In the tumour target area, 48 vascular patterns 
were scored, abrupt ending vessels were most frequently 
reported (n=27, 56%) followed by dotted vessels (n=11, 
Figure 2 Consort diagram i-scan multicentre trial NCT02285426 (clinicaltrials.gov). *The non-lung cancer diagnosis found 
metastasis of melanoma, metastasis of liposarcoma, malignant mesothelioma, pulmonary lymphoma localisation and a 
papillary adenoma. The most frequently found reason for exclusion in the screened patients was an alternative explanation 
found by CT or positron emission tomography scan for the presumed lung cancer suspected on chest X-ray on referral and 
prior radiotherapy treatment involving the central airways.
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23%) and spiral or tortuous vessel (n=10, 21%, figure 1, 
table 2). No clear correlation could be detected between 
vascular pattern and histology outcome in the entire group 
(p=0.339, table 4). When focusing on the AC versus SqCC, 
abrupt ending vessels were more often detected in SqCC 
but no significant correlation was reached between vascular 
pattern and subtype of NSCLC (p=0.116).
hd bronchoscopy visual grade and vascular pattern 
characterisation of central airways
Besides the tumour targets, 51 additional lesions were 
detected in 35 patients by the bronchoscopist not detected 
by the CT and/or positron emission tomography (PET) 
scans. In 22 patients, one additional lesion was detected; in 
10 patients two, and in 3 patients three additional, anatom-
ically separated, lesions.
The visual grade classification of these lesions was 
graded as normal in 4 cases, abnormal in 35, suspicious in 
9 and as tumour in 3 cases (table 2). Pathology outcome 
of the additional lesions detected is available for all 51 
lesions and listed in table 3, and vascular pattern charac-
terisation is reported in 50 lesions (table 2).
Pathology outcome was grouped in two categories: 
normal to moderate dysplasia (low-risk/normal) and 
severe dysplasia to invasive carcinoma (high-risk/
invasive). A significant correlation was found between 
vascular pattern and outcome (p<0.001, table 5). 
Non-target lesions with spiral/tortuous vessel pattern 
were significantly more frequent in the benign group 
whereas abrupt ending vessels were only detected in the 
high-grade dysplasia to invasive carcinoma group.
correlation between blinded and unblinded evaluation and 
differences between image enhancement settings
As described in the ‘Methods’ section, the bronchoscopist 
responsible for the diagnostic procedure inspected the 
bronchial tree with all three imaging modes in random 
order (to avoid systematic scope lesions) and subse-
quently sampled all abnormal lesions and performed 
all diagnostic procedures as indicated and following 
local protocol. Four readers blinded for all patient and 
Table 1 baseline characteristics i-scan multicentre study
Baseline characteristics, n=107 N %
Age (median; range 23–85 years) 67
Gender (female:male) 32:75 30:70
Performance status
  ECOG 0 43 40
  ECOG 1 50 47
  ECOG 2 12 11
  ECOG 3 1 1
Preprocedure evaluation (available imaging prior to 
bronchoscopy
  CT thorax 92%
  PET-CT 76%
Localisation tumour target lesion
  LUL 30 28
  LLL 9 8
  RUL 45 42
  ML 10 9
  RLL 18 17
Clinical TNM stage (v7) prior to bronchoscopy
  Ia 16 15
  Ib 8 8
  IIa 10 9
  IIb 3 3
  IIIa 40 37
  IIIb 7 7
  IV 23 22
Bronchoscopy details
Sedation for bronchoscopy
  None 15 14
  Midazolam (mean dose: 
4.72±0.4 mg, range 1.3–9.0 mg)
25 23
  Propofol 39 36
  General anaesthesia 28 26
Study procedure time (min) 11±0.8
Use of fluoroscopy 29 27
Complications 10 9
  Haemorrhage needing topical 
agents
5 4.7
  Severe haemorrhage 0 0
  Dyspnoea 1 0.9
ECOG, Eastern Cooperative Oncology Group; LLL, left lower lobe; 
LUL, left upper lobe; ML, middle lobe;  PET, positron emission 
tomography; RLL, right lower lobe; RUL, right upper lobe; TNM, 
tumour, node, metastases.
Table 2 High-definition bronchoscopy findings 5 11–13
Bronchoscopy outcome
Target tumour
Secondary 
lesions
N % N %
Visual grade 106 51
  Normal 40 37 4 8
  Abnormal 3 3 35 69
  Suspicious 7 7 9 18
  Tumour 56 52 3 6
Vascular pattern 48 50
  Spiral/tortuous vessel 
pattern
10 21 38 76
  Dotted vessels 11 23 9 18
  Abrupt ending vessels 27 56 3 6
Definitions for visual grade and vascular pattern described in 
‘Methods’ section and in refs. 5 11–13 
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procedure-related information retrospectively analysed 
the videos of the bronchoscopy in random order and 
scored all abnormalities independently.
The interobserver analysis summarised in table 6 shows 
excellent correlation on the visual grade classification 
(Cohen’s kappa >0.6) for all imaging modalities and 
poor to moderate correlation on the vascular pattern 
classification (Cohen’s kappa >0.2, table 6).
In the blinded evaluation, less lesions were reported 
using SE imaging mode (i-scan1, p=0.0353, table 7) and 
significantly more vascular lesions using SE+TE imaging 
mode (i-scan2, p=0.0050) were reported compared 
with the HD setting. Visual grade classification was not 
different between the different settings. Overall the 
total number of lesions detected with visual grading 
and vascular pattern classification was not significantly 
different between blinded and unblinded reading 
(p=0.0631 and 0.1489, respectively).
clinical impact of detected additional lesions
In 11 lesions found in nine patients (21.6% and 8.4%, 
respectively), a clinically relevant diagnosis was obtained 
Table 3 Bronchoscopy pathology outcome
Bronchoscopy pathology outcome
Target tumour Secondary lesions Control biopsies
N % N % N %
Pathology outcome 107 51 53
Normal – – 15 29 33 62
Inflammation – – 17 33 19 36
Hyperplasia – – 2 4 – – 
Squamous metaplasia – – 3 6 1 2
Mild dysplasia – – 3 6 – – 
Moderate dysplasia – – 0 0 – – 
Severe dysplasia – – 1 2 – – 
CIS – – 1 2 – – 
Invasive carcinoma 107 100 9 18 – – 
  NSCLC—SqCC 43 40 1 2 – – 
  NSCLC—AC 39 36 7 14 – – 
  NSCLC—LCNOS 5 5 – – – – 
  LCNEC 2 2 – – – – 
  SCLC 11 10 – – – – 
  Typical carcinoid 6 6 – – – – 
  Mucoepidermoid cell carcinoma 1 1 – – – – 
  LGSDC* – – 1 2 – – 
*Published as case report.18
AC, adenocarcinoma; CIS, carcinoma in situ; LCNEC, large cell neuroendocrine carcinoma; LCNOS, large cell not otherwise classified; 
LGSDC, low-grade salivary duct cell carcinoma; NSCLC, non-small cell lung cancer, SCLC, small cell lung cancer; SqCC, squamous cell 
carcinoma. 
Table 4 Correlation between vascular pattern and 
pathology outcome of the target tumour lesions (n=48 
lesions with vascular patterns classified) 
Target tumour vascular 
lesions (n=48) Vascular pattern
Pathology outcome
Spiral/
tortuous Dotted
Abrupt 
ending
Adenocarcinoma 5 4 4
Squamous cell carcinoma 3 4 14
LCNOS 1 1 1
SCLC 1 2 4
Typical carcinoid 0 0 4
Fisher’s exact testing is not significant:  p = 0.339. No vascular 
pattern classification available of the mucoepidermoid cell 
carcinoma (n = 1) and LCNEC’s (n = 2). 
LCNEC, large cell neuroendocrine carcinoma; LCNOS,  large cell 
not otherwise classified; SCLC, small cell lung cancer. 
Table 5 Correlation between vascular pattern and 
pathology outcome of second, anatomically separated 
lesions detected (n=48 classified lesions) 
Secondary vascular lesions 
(n=51) Vascular pattern
Pathology outcome
Spiral/
tortuous Dotted
Abrupt 
ending
Normal – Moderate dysplasia 36 4 0
Severe dysplasia – Invasive 
carcinoma
3 5 3
Fisher’s exact testing shows a significant relation;  p = 0.000. 
 o
n
 30 July 2018 by guest. Protected by copyright.
http://bmjopenrespres.bmj.com/
BM
J O
pen Resp Res: first published as 10.1136/bmjresp-2018-000295 on 18 May 2018. Downloaded from 
van der Heijden EHFM, et al. BMJ Open Resp Res 2018;5:e000295. doi:10.1136/bmjresp-2018-000295 7
Open Access
from an anatomically distinct location. Pathology 
outcome in these lesions ranged from severe dysplasia 
(n=1) to invasive malignancies (AC (n=7), SqCC (n=1), 
carcinoma in situ (n=1) and low-grade salivary duct cell 
carcinoma (n=1))18 (table 3). In two patients, this finding 
resulted in additional treatments with curative intend, in 
one patient proof of stage IV due to contralateral pulmo-
nary metastasis was obtained preventing additional diag-
nostic procedures. In the remaining six patients, tumour, 
node, metastases (TNM) stage was influenced but disease 
stage not altered, mostly since stage IV disease was diag-
nosed based on extrapulmonary metastases. Details of 
these individual patient characteristics and findings are 
listed in table 8.
dIscussIon
This investigator-initiated, randomised, controlled, cross-
over, multicentre study shows that i-scan image enhance-
ment technology in diagnostic bronchoscopy readily 
detects vascular patterns in airway epithelial layer. In 
this study, approximately half of the patients presented 
with endobronchial visible tumours. Additional lesions 
were detected with HD+ bronchoscopy and image 
enhancement techniques in one-third of all patients. 
From these detected lesions, 22% had a clinical relevant 
pathology outcome, potentially influencing treatment. 
These lesions were found in 8.4% of the patients and 
altered treatment or prevented additional procedures in 
3%. A significant correlation was found with pathology 
outcome and independently classified vascular pattern 
for additional lesions. Abrupt ending vessels and dotted 
vessel patterns are indicative for high-grade preinvasive 
or invasive malignancy. Characterisation of the vascular 
patterns on the visible tumours did not reach signifi-
cance to differentiate but abrupt ending vessels were 
more frequently found in SqCC.
Zaric found a correlation between dotted vessels and 
AC, and abrupt ending and tortuous vessels and SqCC 
in 65 patients with endobronchially visible tumours 
using NBI.13 Our study confirms that in SqCC abrupt 
ending vessels are more frequently found but dotted 
vessels were equally scored in AC and SqCC. Compared 
with the study by Zaric,13 our group with visible 
NSCLC’s was smaller since we studied all patients with 
suspected lung cancer and did not limit inclusion to 
central tumours only. Furthermore, we had a relatively 
high number of carcinoids and small cell carcinomas 
which may explain this discrepancy. Another expla-
nation may be that all earlier studies used a consen-
sus-based classification of vascular patterns whereas in 
our study experienced bronchoscopists independently 
classified the found patterns (unblinded using all image 
enhancement settings in random order per patient at 
the different study centres and blinded in randomised 
order in the central reading). The low interobserver 
agreement for classification of vascular patterns (kappas 
of 0.23–0.26) shows that agreement in classification is 
poor despite the experience level. This may be caused 
by the fact that often some parts of the tumour appear 
to have mixed vascular patterns. Possibly only extreme 
presentations with singular dotted or abrupt ending 
vessels are more easily classified and mixed patterns are 
likely to be judged as tortuous or spiral types. To avoid 
human error in classification, an automated algorithm 
may be useful but this will require a very large dataset 
of images with known pathology outcome. The present 
dataset does not allow such an automated evaluation 
(unpublished observation). There is no principal tech-
nological argument in favour or against superiority of 
NBI or i-scan over the other. Although in pulmonology 
more studies have been published using NBI compared 
with i-scan, in gastroenterology i-scan technology has 
been widely established as a tool for optical diagnosis.16
The detection of additional lesions is clinically relevant. 
In one-third of the patients with suspected lung cancers, 
additional lesions were detected. In our study in 8.4% of 
Table 6 Cohen’s kappa interobserver agreement (±SE)
HD+ SE (i-scan1) SE+TE (i-scan2)
Kappa P values Kappa P values Kappa P values
Visual grade 0.616±0.073 0.0000 0,631±0.078 0.0000 0.683±0.094 0.0000
Vascular pattern 0.261±0.084 0.0010 0.228±0.101 0.0119 0.303±0.071 0.0000
HD+, high-definition bronchoscopy; SE, surface enhancement; TE, tone enhancement.
Table 7 Wilcoxon signed-rank test i-scan1 and i-scan2 compared with high-definition (HD+) bronchoscopy and blinded 
randomised evaluation compared with unblinded primary evaluation in randomised order
SE (i-scan1) vs HD+ SE+TE (i-scan2) vs HD+ Blinded vs unblinded
Z P values Z P values Z P values
Visual grade 1.092 0.2747 −0.031 0.9755 −1.859 0.0631 
Vascular pattern 2.105 0.0353 −2.807 0.0050 −1.443 0.1489
SE, surface enhancement; TE, tone enhancement.
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the patients, lesions were detected of high-grade preinva-
sive or invasive nature. This finding second lesions with 
clinically relevant pathology was the sole factor affecting 
stage and/or treatment in 3% of these patients. This 
finding supports the results of a study by van Boerdonk8 
in which patients with high-grade dysplasia were carefully 
followed using CT and AFB. Surveillance of 164 subjects 
with preinvasive lesions detected 61 lung cancers in 55 
subjects after 16.5 months (median). In total, 38% of 
those were detected by CT, and 62% were detected by 
AFB and 60% of the cancers developed from separate, 
rather than initial lesion sites.8
In our study, the majority of patients where additional 
high-grade preinvasive or invasive carcinomas were 
detected had stage IV disease. However, our findings 
support careful full inspection of the airways to remain 
mandatory and HD+ image enhancement techniques will 
aid the detection and biopsy of such additional lesions. 
Follow-up bronchoscopy may be considered in selected 
cases and is indicated in high-grade premalignant 
lesions.7 8 11–13 With this study we do not advocate a role 
for HD+ bronchoscopy in lung cancer screening since 
the clinical relevance is too low. For daily use the ability 
to see and compare different settings of image enhance-
ment techniques simultaneous seems the optimal setting 
but this cannot be established in this study.
study lIMItAtIons
One of the limitations of this study is that the endos-
copist was unblinded for the different settings and had 
to determine which lesions to biopsy. Therefore, when 
the blinded readers detect additional lesions, biopsy 
samples were available only when the initial endoscopist 
also had detected this lesion. In the blinded evaluation, 
the combined SE and TE (i-scan2) mode significantly 
more synchronous lesions were detected (p=0.005) and 
using SE significantly less compared with HD+ bronchos-
copy alone (p=0.0353). However, in the interobserver 
analysis we found no significant differences between 
the blinded and unblinded detection rates. Combining 
multiple imaging modes may in fact decrease the number 
of false positives as described using AFB but our study 
cannot answer this question.
A further limitation in the design of this study is that the 
used EB1990i HD+ bronchoscope has a working channel 
of 1.2 mm for which no disposable biopsy forceps was 
available. Therefore, for taking biopsies and all additional 
diagnostic procedures the bronchoscopy was continued 
after switching to a normal WLB. This may have resulted 
in suboptimal biopsy forceps positioning and sampling 
since small lesions may have been more difficult to detect 
without the HD+ image.
Finally, we show that the interobserver agreement for 
vessel pattern classifications is low. Previous studies11–13 
all used consensus-based classification which does not 
resemble everyday practice. Before the start of the study, 
all involved bronchoscopists were trained in the different 
vascular patterns and sample figures were included in 
the case report file for reference. However, given this 
low interobserver agreement and the fact that vessel 
patterns may not be uniformly present over the total 
surface of tumours, human error in classification will 
be of influence. In the gastroenterology, the need for 
better classification was also recognised16 and training 
has been underlined.16 19 In our experience, the use of 
simultaneous dual image viewing of both i-scan1 and 
i-scan2 (available on top-end video processors) is the 
optimal mode for rapid and thorough evaluation and 
classification.
In conclusion, this multicentre randomised controlled 
study shows that i-scan image enhancement HD+ bron-
choscopy readily detects centrally located tumours and 
detects additional lesions in approximately one-third of 
the patients with lung cancer. In a considerable number 
of patients (8%), these additional findings had clinical 
relevant pathology outcome and was the only factor to 
change stage and treatment in 3% of the patients. Abrupt 
ending or dotted vessels on these additional lesions are 
indicative of malignant behaviour and biopsies should be 
taken. Our findings support the importance of careful 
evaluation of the airways and addressing vessel characteri-
sation as reported in earlier studies using NBI imaging11 13 
but also shows that this classification is challenging and 
the interobserver agreement for vascular pattern classifi-
cation is low. Additional training for correct classification 
of vascular patterns is strongly advised.
In all patients with suspected lung cancer, the central 
airways should be carefully inspected and the use of 
HD+ bronchoscopes with image enhancement tech-
niques helps detecting additional lesions which may 
influence treatment and follow-up strategy in a small 
subset of patients.
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